Can levofloxacin cause skin pigmentation changes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levofloxacin and Skin Pigmentation

Yes, levofloxacin can cause skin pigmentation changes, though this is a rare cutaneous adverse effect. While the common cutaneous reactions associated with levofloxacin include rash, pruritus, and photosensitivity (occurring in 0.2-0.4% of patients), skin hyperpigmentation has been documented in case reports 1, 2.

Evidence of Levofloxacin-Induced Skin Pigmentation

  • Levofloxacin has been implicated in causing dark hyperpigmentation, particularly in sun-exposed areas, suggesting a photosensitive distribution pattern 2
  • A case report documented brown-gray hyperpigmentation in a photosensitive distribution after levofloxacin exposure in an immunocompromised patient 2
  • Another case report showed dark hyperpigmentation appearing on the lower limbs, predominantly on the anterior aspects of the legs, after treatment with a regimen that included levofloxacin 1

Mechanism and Histological Findings

  • Histological examination in reported cases revealed dark, perivascular and interstitial deposits throughout the dermis 1
  • These deposits stained positive with both Fontana-Masson (for melanin) and Perls (for iron) stains, suggesting the presence of both melanin and iron in the affected skin 1
  • In one case, infrared microspectroscopy was able to identify the medication in the dermis of involved skin 1
  • The exact mechanism appears similar to minocycline-induced hyperpigmentation, with deposits of iron and/or melanin within the dermis 1

Risk Factors and Clinical Presentation

  • Photosensitivity appears to be a contributing factor, with pigmentation often developing in sun-exposed areas 2
  • Immunocompromised status may increase risk, as seen in a case involving an orthotopic liver transplant patient 2
  • Longer duration of therapy may increase the risk, similar to other drug-induced pigmentation disorders 1
  • The pigmentation typically develops several weeks after initiation of antibiotic therapy 1

Management

  • Discontinuation of levofloxacin typically leads to gradual resolution of the hyperpigmentation over several weeks 2
  • No specific treatment is required beyond drug discontinuation 1, 2
  • Patients should be advised to use sun protection measures when taking levofloxacin to minimize photosensitivity reactions 3

Other Known Cutaneous Adverse Effects of Levofloxacin

  • Rash, pruritus, and photosensitivity occur in 0.2-0.4% of patients taking levofloxacin 3
  • Photosensitivity is a class effect of fluoroquinolones, with levofloxacin having a lower photosensitizing potential compared to some other quinolones 4
  • Serious cutaneous reactions like Stevens-Johnson syndrome are rare but have been reported with fluoroquinolones 4

Clinical Implications

  • When prescribing levofloxacin, clinicians should be aware of this rare but documented adverse effect 1, 2
  • In patients developing unusual skin pigmentation while on levofloxacin, consider drug-induced hyperpigmentation in the differential diagnosis 2
  • Patients taking multiple medications pose a diagnostic challenge when hyperpigmentation develops, requiring careful assessment of temporal relationships and resolution patterns after drug discontinuation 2
  • Patients should be counseled about photosensitivity and advised to use sun protection while taking levofloxacin 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.